New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Dyadic International Inc. (DYAI) vs Passage Bio, Inc. (PASG)

Dyadic International Inc. and Passage Bio, Inc. are both Biotechnology companies. Dyadic International Inc. and Passage Bio, Inc. are of similar size ($12.5M and $11.6M). Across the 8 metrics below, Dyadic International Inc. leads on 5 and Passage Bio, Inc. on 3.

Valuation

Metric DYAI PASG Biotechnology median
P/E n/m n/m 8.49
P/S 3.60 — 8.56
P/B n/m 253.58 2.04
Price to free cash flow n/m n/m 23.84
EV/EBITDA n/m 0.21 0.69
EV/Sales 3.28 — 8.00
Earnings yield (70.83%) (262.60%) (35.81%)
Free cash flow yield (63.36%) (257.29%) (25.41%)

Profitability

Metric DYAI PASG Biotechnology median
Gross margin 17.85% — 70.18%
Operating margin (237.12%) — 0.00%
Net margin (226.87%) — 0.00%
Free cash flow margin (227.93%) — 0.00%
Return on equity (47,316.89%) (212.27%) (51.58%)
Return on assets (71.43%) (69.68%) (45.91%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DYAI PASG Biotechnology median
Revenue growth (TTM) (7.64%) — 7.20%
EPS growth (last fiscal year) (15.00%) 32.94% 29.04%
Revenue growth, 5-year CAGR 14.04% — 9.54%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric DYAI PASG Biotechnology median
Debt to equity (1.96) 0.00 0.00
Current ratio 1.69 1.00 4.79
Net debt to EBITDA 0.49 0.96 1.01

Dividend

Metric DYAI PASG Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DYAI PASG Biotechnology median
Market cap 12.46m 11.62m 150.57m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack